Morin inhibits cell proliferation and fibronectin accumulation in rat glomerular mesangial cells cultured under high glucose condition

被引:25
作者
Ke, Ya-qiong [1 ]
Liu, Chao [1 ]
Hao, Jian-bo [1 ]
Lu, Ling [1 ]
Lu, Nan-nan [1 ]
Wu, Zhao-ke [1 ]
Zhu, Shen-shen [1 ]
Chen, Xi-ling [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 2, Dept Gerontol, 2 Jingba Rd, Zhengzhou 450000, Henan, Peoples R China
关键词
Morin; Diabetic nephropathy; Mesangial cells (MCs); Extracellular matrix (ECM); ACTIVATED PROTEIN-KINASES; DIABETIC-NEPHROPATHY; EXTRACELLULAR-MATRIX; EXPRESSION; PATHWAY; GROWTH; BETA; HYPERGLYCEMIA; PROGRESSION; MODULATION;
D O I
10.1016/j.biopha.2016.09.088
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Morin, is a natural bioflavonoid isolated from Chinese herbs of the Moraceae family, has been reported to possess antidiabetic activity. However, the role of morin on glomerular mesangial cells (MCs) proliferation and extracellular matrix (ECM) accumulation in diabetic condition is still unclear. Therefore, in this study, we investigated the role of morin on cell proliferation and ECM accumulation in rat glomerular MCs cultured under high glucose (HG) condition. Our results showed that morin inhibited HG-induced MC proliferation, arrested HG-induced cell-cycle progression, reversed HG-inhibited expression of p21(Waf1/Cip1) and p27(Kip1). It also inhibited HG-induced ECM expression, ROS generation and NOX4 expression in MCs. Furthermore, morin suppressed HG-induced phosphorylation of p38 MAPK and JNK1/2 in MCs. These data suggest that morin inhibits HG-induced MC proliferation and ECM expression through suppressing the activation of p38 MAPK and JNK signaling pathways. Thus, morin may be useful for the prevention or treatment of diabetic nephropathy. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:622 / 627
页数:6
相关论文
共 29 条
[1]
Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy [J].
Adhikary, L ;
Chow, F ;
Nikolic-Paterson, DJ ;
Stambe, C ;
Dowling, J ;
Atkins, RC ;
Tesch, GH .
DIABETOLOGIA, 2004, 47 (07) :1210-1222
[2]
ADLER S, 1994, J AM SOC NEPHROL, V5, P1165
[3]
Athira K., 2016, J BIOCH MOL TOXICOL
[4]
Monitoring of antioxidative effect of morine in alloxan-induced diabetes mellitus in the laboratory rat [J].
Bartosíkova, L ;
Necas, J ;
Suchy, V ;
Kubínová, R ;
Veselá, D ;
Benes, L ;
Bartosík, T ;
Illek, J ;
Salplachta, J ;
Klusákova, J ;
Bartosová, L ;
Strnadová, V ;
Frána, P ;
Fránová, J .
ACTA VETERINARIA BRNO, 2003, 72 (02) :191-200
[5]
Oxidative stress and advanced glycation in diabetic nephropathy [J].
Coughlan, Melinda T. ;
Mibus, Amy L. ;
Forbes, Josephine M. .
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES, 2008, 1126 :190-193
[6]
3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: Implications for diabetic nephropathy [J].
Danesh, FR ;
Sadeghi, MM ;
Amro, N ;
Philips, C ;
Zeng, LX ;
Lin, S ;
Sahai, A ;
Kanwar, YS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8301-8305
[7]
Apoptotic effect of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density [J].
Gennero, I ;
Fauvel, J ;
Niéto, M ;
Cariven, C ;
Gaits, F ;
Briand-Mésange, F ;
Chap, H ;
Salles, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) :12724-12734
[8]
Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney [J].
Gorin, Y ;
Block, K ;
Hernandez, J ;
Bhandari, B ;
Wagner, B ;
Barnes, JL ;
Abboud, HE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (47) :39616-39626
[9]
Diabetic nephropathy: Diagnosis, prevention, and treatment [J].
Gross, JL ;
de Azevedo, MJ ;
Silveiro, SP ;
Canani, LH ;
Caramori, ML ;
Zelmanovitz, T .
DIABETES CARE, 2005, 28 (01) :164-176
[10]
The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy [J].
Hodgkinson, AD ;
Bartlett, T ;
Oates, PJ ;
Millward, BA ;
Demaine, AG .
DIABETES, 2003, 52 (03) :846-851